Oxybutynin chloride topical gel for the treatment of overactive bladder Timothy B. Boone Clinical Trials Report 15 May 2009 Pages: 61 - 61
Bladder sensation testing: Where are we? Firouz DaneshgariKimberly Kenton OriginalPaper 15 May 2009 Pages: 65 - 70
Evaluation and management of neurogenic vesicourethral dysfunction in multiple sclerosis Sophie G. FletcherGary E. Lemack OriginalPaper 15 May 2009 Pages: 71 - 78
The evolving physiology of the lower urinary tract: What we are learning and where we need to go Karl-Erik Andersson OriginalPaper 15 May 2009 Pages: 81 - 85
Painful bladder syndrome: Is consensus possible? Melissa R. KaufmanHarriette M. ScarperoRoger R. Dmochowski OriginalPaper 15 May 2009 Pages: 86 - 90
Medication and food issues for overactive bladder/lower urinary tract symptoms: When do we eat? Helene C. MaltzDavid R. StaskinEdward Zoltan OriginalPaper 15 May 2009 Pages: 93 - 97
The importance of monitoring fluid intake during treatment of overactive bladder Lily A. AryaTirsit Asfaw OriginalPaper 15 May 2009 Pages: 98 - 105
Update on interstitial cystitis: Still a bladder disease? John W. Warren OriginalPaper 15 May 2009 Pages: 109 - 113
Update on neuromodulation for frequency, urgency, retention, and neurogenic voiding dysfunction Patrick J. ShenotM. Louis Moy OriginalPaper 15 May 2009 Pages: 114 - 119